Chemo-proteomics in antimalarial target identification and engagement.

Area of Science:

• Medicinal Chemistry
• Parasitology
• Chemical Biology

Background:

• Malaria remains a significant global health challenge, particularly in South America, Asia, and Africa.
• Increasing antimalarial drug resistance necessitates the development of novel therapeutic agents.
• Phenotypic screening has yielded new antimalarial compounds but often lacks target information.

Purpose of the Study:

• To review the application of chemo-proteomics in the discovery and development of antimalarial drugs.
• To highlight the methodologies, advantages, and challenges of using chemo-proteomics for target identification.
• To inform future strategies for antimalarial drug development.

Main Methods:

• Chemo-proteomics techniques for target identification in antimalarial drug discovery.
• Review of experimental design, including methodology, practical considerations, merits, and limitations.
• Analysis of how these methods contribute to validating molecular targets.

Main Results:

• Chemo-proteomics is a valuable tool for identifying molecular targets of novel antimalarial compounds.
• Understanding target information is critical for advancing compounds through clinical development.
• The review synthesizes current knowledge on chemo-proteomics applications in this field.

Conclusions:

• Chemo-proteomics significantly enhances the identification and validation of drug targets for new antimalarial therapies.
• Addressing limitations in chemo-proteomics experimental design will optimize its future use.
• This approach is vital for building a robust pipeline of next-generation antimalarials.